Comment on “Umbilical Artery Leucine‐Rich α‐2 Glycoprotein as a Predictor of Bronchopulmonary Dysplasia in Preterm Infants”

Key Points

• To evaluate the role of umbilical artery leucine-rich α-2 glycoprotein as a predictive marker.
• Commentary on previous findings regarding umbilical artery leucine-rich α-2 glycoprotein.
• Analysis of its association with bronchopulmonary dysplasia.
• Discussion of implications for preterm infants.
• Highlights the potential of umbilical artery leucine-rich α-2 glycoprotein as a predictor.
• Suggests clinical relevance for the management of preterm infants at risk.